You are here

China

'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape

Fierce Biotech

Fri, 06/6/25 - 12:06 pm

Robert F Kennedy Jr.

Ascletis’s daily acne tablet set for China review after Phase III win

Clinical Trials Arena

Thu, 06/5/25 - 09:49 am

clinical trials

China's biotech boom leaves U.S. playing catch-up

Axios

Thu, 05/29/25 - 10:41 am

clinical trials

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

Yahoo/Reuters

Mon, 05/19/25 - 10:33 pm

non-small cell lung cancer

metastatic colorectal cancer

Germany’s Merck drops China surcharge on orders after US-China tariff deal

Pharma Live

Wed, 05/14/25 - 09:53 am

Qilu Pharmaceutical pays $38M upfront for greater China rights to Minghui's ADC

Fierce Biotech

Fri, 05/9/25 - 09:32 am

Qilu Pharmaceutical

Minguhui Pharmaceutical

Illumina outlines $4.18B to $4.26B guidance for 2025 amid China headwinds and strategic cost reductions

MSN/Seeking Alpha

Thu, 05/8/25 - 10:51 pm

AstraZeneca's China woes recede as focus shifts to upcoming readouts

First Word Pharma

Thu, 05/1/25 - 10:54 am

AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China

MSN/Wall St Journal

Tue, 04/29/25 - 08:26 am

This Pharma Company Is Betting Big On A Chinese Ozempic Rival

Forbes

Sun, 04/13/25 - 11:13 pm

Kailera Therapuetics

Trump says ‘major’ tariffs coming on pharmaceuticals

BioPharma Dive

Wed, 04/9/25 - 11:46 am

pharma industry

drug manufacturing

US risks losing biotech edge to China, report warns

BioPharma Dive

Tue, 04/8/25 - 10:56 pm

Bayer acquires rights in Puhe BioPharma cancer drug candidate

Reuters

Wed, 03/26/25 - 10:24 am

ImmuneOnco axes CD47 bispecific as pipeline prioritization pressures hit Chinese biotech

Fierce Biotech

Wed, 03/26/25 - 10:22 am

ImmuneOnco Biopharmaceuticals

AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts

Fierce Biotech

Fri, 03/21/25 - 11:29 am

The key factors shaping China’s biopharma boom

Pharma Voice

Thu, 03/20/25 - 09:57 am

Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says

MSN/Reuters

Mon, 03/10/25 - 11:09 pm

emerging markets

As Tariffs Begin; What Will They Do To Drug Prices And Availability?

Forbes

Wed, 03/5/25 - 11:55 am

China bans imports of Illumina's gene sequencers right after Trump tariff action

MSN/Reuters

Tue, 03/4/25 - 10:46 am

Medical Device Manufacturers Eye Costa Rica as Tariff Uncertainty Shakes up Production Strategies

Medtech Dive

Wed, 02/26/25 - 10:19 pm

device manufacturing

Pages